← back to evidence hierarchy
evidence card · some_cancer_screenings_earlier_than_guidelines

For selected patients, some cancer / CV screenings should start earlier than current guideline age thresholds

H3 ≈ mixed stakes critical
5 posts scored · across 3 accounts · 1 sources

Summary

ACS recently lowered colonoscopy to 45. Some lipid/ASCVD evaluations are reasonable earlier in high-risk lineages. Over-screening has real harms (false positives, biopsies, anxiety); decisions should be individualized.

Five-score assessment

Scores not yet assigned for this card. (Legacy card; will be populated on next refinement.)

Scope

Population
patients with family history, elevated risk, or specific biomarkers
Intervention
starting screening before guideline age
Outcome
mortality reduction vs over-diagnosis
Not supported for
  • blanket recommendation to screen everyone earlier — balance of benefit/harm differs by test

Evidence sources

Account mentions